Abstract:Highlights the types, risk factors, and therapeutic strategies associated with cerebral palsy (CP). It emphasizes the complex interplay of genetic, environmental, and maternal factors, along with current therapeutic approaches aimed at managing symptoms and improving patient outcomes. Background Cerebral palsy (CP) is a common neurodevelopmental disorder characterized by impaired mobility and posture caused by brain injury or abnormal development. CP relates to a variety of neurological mechanisms and pathways that impact the type and severity of motor disability, as well as comorbidities. The heterogeneity in clinical phenotype, pathogenesis, and etiology poses significant challenges for effective therapeutic intervention. Objectives The review aims to provide a comprehensive analysis of the neurobiological mechanisms underlying CP and evaluate current and prospective therapeutic strategies, highlighting the necessity for targeted interventions to address the disorder's multifaceted nature. Methods A thorough literature review was conducted, focusing on studies published in peer‐reviewed journals that explore the pathophysiological mechanisms, clinical interventions, and therapeutic strategies for CP. Results The pathogenesis of CP involves a complex interplay of genetic, environmental, and perinatal factors leading to brain injury. Inflammatory processes, oxidative stress, and excitotoxicity are critical in CP development. Current therapeutic approaches primarily focus on symptom management through physical and occupational therapy, as well as pharmacological interventions. Emerging therapies, including anti‐inflammatory agents, antioxidants, and neuroprotective and neurotrophic agents, show potential but require further validation. Notably, although steroids provide anti‐inflammatory benefits, their use in pediatric patients raises concerns regarding long‐term adverse effects such as osteoporosis. Conclusion Despite advances in understanding CP's neurobiological underpinnings, effective therapeutic targets remain elusive. A comprehensive approach addressing CP's heterogeneity is essential. Future research should emphasize in‐depth evaluations of the efficacy and safety of therapeutic agents, particularly in pediatric populations, to develop targeted and effective treatments for CP.

Genetic investigations in cerebral palsy

The Genetic Puzzle of Cerebral Palsy: Results of a Monocentric Study

Clinical characteristics suggestive of a genetic cause in cerebral palsy: A systematic review

Clinical utility of a genetic diagnosis in individuals with cerebral palsy and related motor disorders

Comprehensive whole-genome sequence analyses provide insights into the genomic architecture of cerebral palsy

Exome sequencing reveals genetic heterogeneity and clinically actionable findings in children with cerebral palsy

[Advances in Genetic Research of Cerebral Palsy].

Genetic Spectrum Identified by Exome Sequencing in a Chinese Pediatric Cerebral Palsy Cohort

Mutations Disrupting Neuritogenesis Genes Confer Risk for Cerebral Palsy.

In-depth analysis reveals complex molecular aetiology in a cohort of idiopathic cerebral palsy

Characterization of Clinical MRI Findings in Moderately-Late Preterm Infants Diagnosed with Cerebral Palsy: A Single Center Retrospective Study

Exome-wide Association Study Identified Genetic Variants Contributing to the Risk of Cerebral Palsy

Neurobiological Insights Into Cerebral Palsy: A Review of the Mechanisms and Therapeutic Strategies

Cerebral Palsy Heterogeneity: Clinical Characteristics and Diagnostic Significance from a Large-Sample Analysis

Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants

Exome sequencing in a Chinese cohort of children with cerebral palsy identifies likely pathogenic variants

Genetic Variants in the HLA Region Contribute to the Risk of Cerebral Palsy.

Current approach to cerebral palsy

Major structural congenital anomalies and causal pathways in people with cerebral palsy

The genetic etiology is a relevant cause of central precocious puberty

Clinical and Genetic Characteristics and Prenatal Diagnosis of Patients Presented GDD/ID with Rare Monogenic Causes